CLINICAL_TRIALS
trial_result
· 2025-04-03
Clinical Trial Update: Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity [Phase 3]
Summary
A Phase 3 trial assessing the efficacy and safety of semaglutide for obesity in participants from Thailand and South Korea has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2025-04-03